Ledger.Open graph →
SEC Form D · filed October 11, 2019

Clear Creek Bio, Inc

Offering
$1.6M
Sold
$1.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

David S. Scadden · Cambridge, MADirectorAndrew S. Levin · Cambridge, MADirectorVikram S. Kumar · Cambridge, MAExec · DirectorBurt S. Adelman · Cambridge, MADirectorRichard Q. Opler · Parker, CODirectorLaurent Forget · Luxembourg, LuxembourgExec · DirectorMichael Gingrich · St. Louis, MODirectorGuillaume Le Bouar · Luxembourg, LuxembourgDirectorSteve Hulteng · Kirkland, WADirectorChanning T. Lushbough · Pasadena, CAExec · DirectorSamuel Hodges · San Francisco, CADirectorNicholas Shalek · San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗